Dynavax (DVAX): Heplisav Alone Is Worth $30 - Cowen

November 10, 2017 6:53 AM EST Send to a Friend
Cowen analyst, Phil Nadeau, reiterated his Outperform rating on shares of Dynavax Technologies (NASDAQ: DVAX) after the company announced that ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login